Trial Profile
A Double-blinded, Placebo-controlled Study to Evaluate the Tolerability and Efficacy of Enstilar (Calcipotriene and Betamethasone Dipropionate) Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jan 2021
Price :
$35
*
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 13 Nov 2019 Status changed from recruiting to completed.
- 29 Apr 2019 Planned End Date changed from 30 May 2019 to 1 Sep 2019.
- 29 Apr 2019 Planned primary completion date changed from 30 Apr 2019 to 29 Jul 2019.